Literature DB >> 9584251

B-mode-guided vector-A-mode versus A-mode biometry to determine axial length and intraocular lens power.

O Bergès1, M Puech, M Assouline, L Letenneur, M Gastellu-Etchegorry.   

Abstract

PURPOSE: To compare prospectively the reproducibility and accuracy of B-mode-guided biometry with those of A-scan biometry using a conventional A-mode probe to calculate intraocular lens (IOL) power.
SETTING: Department of Ophthalmology, Hôtel-Dieu de Paris, France.
METHODS: The axial length (AL) in 87 eyes of 72 candidates for cataract surgery was determined by B-mode-guided vector-A-mode and A-mode biometry using an Ophthascan S Ultrasound imager. Patients were assigned to one of two groups based on the B-mode biometry: nonmyopic (AL < 24.5 mm; n = 54) or myopic (AL > 24.5 mm; n = 33). Postoperative refractive results were compared with attempted values.
RESULTS: Mean AL variance was significantly greater when using the A-mode than the B-mode: 0.157 mm +/- 0.260 (SD) versus 0.015 +/- 0.018 mm in the myopic group (P < .001) and 0.024 +/- 0.024 +/- 0.045 versus 0.009 +/- 0.011 mm in the nonmyopic group (P < .001). More eyes having B-mode biometry achieved a final refraction within +/- 0.50 diopter (D) of the attempted refraction (63 and 43%, respectively; P < .05). No deviation greater than 1.60 D was observed with the B-mode in the myopic or nonmyopic group. Three cases with a such a deviation (up to 2.24 D) would have been observed had A-mode-based biometry been chosen for the IOL power calculation. In the myopic group, attempted postoperative refraction was within +/- 0.50 D in 78% of eyes having B-mode biometry compared with 65% having A-mode. This difference was not statistically significant. CONCLUSION> These results suggest that the reproducibility and accuracy of AL measurements are significantly better with B-mode-guided A-mode biometry than with A-mode biometry in myopic and nonmyopic eyes.

Entities:  

Mesh:

Year:  1998        PMID: 9584251     DOI: 10.1016/s0886-3350(98)80297-6

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  6 in total

1.  The impact of off the visual axis retinoscopy on objective central refractive measurement in adult clinical practice: a prospective, randomized clinical study.

Authors:  E Tay; L Mengher; X-Y Lin; V Ferguson
Journal:  Eye (Lond)       Date:  2011-04-15       Impact factor: 3.775

2.  Ocular biometry through fully refocused steady-state magnetic resonance imaging sequence: reliability and agreement with the IOLMaster® 500.

Authors:  Lorenzo Ismael Perez-Sanchez; Julia Gutierrez-Vazquez; Maria Satrustegui-Lapetra; Francisco Ferreira-Manuel; Juan Jose Arevalo-Manso; Juan Jesus Gomez-Herrera; Juan Jose Criado-Alvarez
Journal:  Int Ophthalmol       Date:  2021-02-23       Impact factor: 2.031

3.  Accuracy of segmented measurement of axial length in ultra-high myopia filled with silicone oil using immersion B-scan ultrasonography.

Authors:  Qing-Hua Yang; Hong-Tao Zhang; Xiao-Qi Li; Bing Chen; Zhao-Hui Li; Yi-Fei Huang; Xin Jin; Ying Zhang; Li-Qiang Wang
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

4.  Accuracy of axial length measurements from immersion B-scan ultrasonography in highly myopic eyes.

Authors:  Qing-Hua Yang; Bing Chen; Guang-Hua Peng; Zhao-Hui Li; Yi-Fei Huang
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

5.  Agreement of IOL power and axial length obtained by IOLMaster 500 vs IOLMaster 500 with Sonolink connection.

Authors:  Sabong Srivannaboon; Chareenun Chirapapaisan; Patchara Nantasri; Mathinee Chongchareon; Pratuangsri Chonpimai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-01-12       Impact factor: 3.117

6.  Outcomes of cataract operations in extreme high axial myopia.

Authors:  Jasmine K M Lam; Tommy C Y Chan; Alex L K Ng; Vanissa W S Chow; Victoria W Y Wong; Vishal Jhanji
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-06-16       Impact factor: 3.117

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.